Why the study?
Although LMCA PCI is an acceptable revascularization strategy in stable coronary artery disease, studies on long-term clinical outcomes of LMCA PCI in patients presenting with ACS were limited.
Does target lesion location in the left main coronary artery (LMCA) compared to non-LMCA lesions increase the risk of 2-year major adverse cardiovascular and cerebrovascular events in patients with acute coronary syndrome undergoing PCI?
Cohort (n=6,429)
No
Does target lesion location in the left main coronary artery (LMCA) compared to non-LMCA lesions increase the risk of 2-year major adverse cardiovascular and cerebrovascular events in patients with acute coronary syndrome undergoing PCI?
Answers are grounded in this paper and cite their sources.
In patients presenting with acute coronary syndrome, undergoing PCI for a left main coronary artery target lesion is an independent predictor of a more than two-fold higher risk of myocardial infarction at 2 years compared to non-LMCA PCI.
Objectives. We aim to evaluate long-term outcomes after left main coronary artery (LMCA) percutaneous coronary intervention (PCI) in patients presenting with acute coronary syndrome (ACS). Background. PCI of the LMCA has been an acceptable revascularization strategy in stable coronary artery disease. However, limited studies on long-term clinical outcomes of LMCA PCI in ACS patients are available. Methods. A total of 6429 consecutive patients with ACS undergoing PCI in Fuwai Hospital in 2013 were enrolled. Patients are divided into LMCA group and Non-LMCA group according to whether the target lesion was located in LMCA. Prognosis impact on 2-year major adverse cardiovascular and cerebrovascular events (MACCE) is analyzed. Results. 155 (2.4%) patients had target lesion in LMCA, while 6274 (97.6%) patients belong to the non-LMCA group. Compared with non-LMCA patients, LMCA patients have generally more comorbidities and worse baseline conditions. Two-year follow-up reveals that LMCA patients have significantly higher rate of cardiac death (2.6% vs. 0.7%, p=0.034 ), myocardial infarction (7.1% vs. 1.8%, p<0.001 ), in-stent thrombosis (4.5% vs. 0.8%, p<0.001 ), and stroke (7.1% vs. 6.4%, p=0.025 ). After adjusting for confounding factors, LMCA remains independently associated with higher 2-year myocardial infarction rate (HR = 2.585, 95% CI = 1.243–5.347, p=0.011 ). Conclusion. LMCA-targeted PCI is an independent risk factor for 2-year myocardial infarction in ACS patients.
No takes yet. Share an insight, caveat, or question.
Jia et al. (2020) conducted a cohort in Acute coronary syndrome undergoing percutaneous coronary intervention (n=6,429). Left main coronary artery (LMCA) target lesion PCI vs. Non-LMCA target lesion PCI was evaluated on 2-year myocardial infarction (component of major adverse cardiovascular and cerebrovascular events [MACCE]) (HR 2.585, 95% CI 1.243-5.347, p=0.011).
Synapse has enriched 10 related papers. Consider them for comparative context: